Shiyang Zhu

No ORCID on file · 5 papers in corpus
article 2023
The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102572

BACKGROUND: When ovarian endometrioma coexist with adenomyosis, the risk of postoperative recurrence increased. How is the effect of levonorgestrel-releasing intrauterine system (LNG-IUS) on symptomatic recurrence for those patients was unk…

article 2022
Clinical presentation of perineal endometriosis and prognostic nomogram after surgical resection
BMC women's health ·doi:10.1186/s12905-022-02068-3

BACKGROUND: This retrospective study evaluated the clinical features of perineal endometriosis (PEM) and established a prognostic nomogram for recurrence probability in patients treated with surgical resection. METHODS: This study enrolled…

erratum 2022
Correction: Clinical presentation of perineal endometriosis and prognostic nomogram after surgical resection
BMC women's health ·doi:10.1186/s12905-022-02100-6
article 2020
Interpretation to the American College of Obstetricians and Gynecologists’ Committee Opinion No. 760: dysmenorrhea and endometriosis in the adolescent
·doi:10.3760/cma.j.issn.2096-2916.2020.0027

Dysmenorrhea is the most common menstrual symptom among adolescent girls and young women. Most adolescents experiencing dysmenorrhea have primary dysmenorrhea. When the patient’s history suggests primary dysmenorrhea and will respond well t…

article 2020
Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05843-5

PurposeHere, we compared endometrioma recurrence rates in patients who have undergone a laparoscopic cystectomy and treated with a gonadotropin-releasing hormone agonist (GnRHa) alone or a GnRHa combined with a levonogestrel intrauterine sy…